BofA/Merrill Downgrades CFX To Underperform
Analysts at BofA/Merrill downgrade Colfax (NYSE: CFX) from "neutral" to "underperform." The target price for CFX has been reduced from $13.00 to $12.50.
CFX’s shares gained 4.06% to reach $11.79 yesterday. More Analyst Ratings here







